Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Public ClinicalTrials.gov record NCT03605862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
Study identification
- NCT ID
- NCT03605862
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Romark Laboratories L.C.
- Industry
- Enrollment
- 1,756 participants
Conditions and interventions
Conditions
Interventions
- Nitazoxanide Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 10, 2018
- Primary completion
- Feb 3, 2019
- Completion
- Feb 3, 2019
- Last update posted
- Apr 13, 2022
2018 – 2019
United States locations
- U.S. sites
- 43
- U.S. states
- 23
- U.S. cities
- 39
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanguard Study Site | Birmingham | Alabama | 35235 | — |
| Vanguard Study Site | Birmingham | Alabama | 35242 | — |
| Vanguard Study Site | Pelham | Alabama | 35124 | — |
| Vanguard Study Site | Hot Springs | Arkansas | 71913 | — |
| Vanguard Study Site | Anaheim | California | 92805 | — |
| Vanguard Study Site | Westminster | California | 92683 | — |
| Vanguard Study Site | Wilmington | California | 90744 | — |
| Vanguard Study Site | Miami | Florida | 33145 | — |
| Vanguard Study Site | Miami | Florida | 33155 | — |
| Vanguard Study Site | Miami | Florida | 33174 | — |
| Vanguard Study Site | Orlando | Florida | 32819 | — |
| Vanguard Study Site | Tampa | Florida | 33609 | — |
| Vanguard Study Site | Stockbridge | Georgia | 30281 | — |
| Vanguard Study Site | Blackfoot | Idaho | 83221 | — |
| Vanguard Study Site | Meridian | Idaho | 83642 | — |
| Vanguard Study Site | Nampa | Idaho | 83686 | — |
| Vanguard Study Site | Evanston | Illinois | 60201 | — |
| Vanguard Study Site | Valparaiso | Indiana | 46383 | — |
| Vanguard Study Site | Louisville | Kentucky | 40207 | — |
| Vanguard Study Site | New Orleans | Louisiana | 70115 | — |
| Vanguard Study Site | New Orleans | Louisiana | 70124 | — |
| Vanguard Study Site | Baltimore | Maryland | 21236 | — |
| Vanguard Study Site | St Louis | Missouri | 63141 | — |
| Vanguard Study Site | Missoula | Montana | 59808 | — |
| Vanguard Study Site | Bellevue | Nebraska | 68005 | — |
| Vanguard Study Site | Las Vegas | Nevada | 89104 | — |
| Vanguard Study Site | Brooklyn | New York | 11229 | — |
| Vanguard Study Site | Raleigh | North Carolina | 27607 | — |
| Vanguard Study Site | Cincinnati | Ohio | 45215 | — |
| Vanguard Study Site | Cleveland | Ohio | 44122 | — |
| Vanguard Study Site | Columbus | Ohio | 43214 | — |
| Vanguard Study Site | Dayton | Ohio | 45424 | — |
| Vanguard Study Site | Medford | Oregon | 97504 | — |
| Vanguard Study Site | East Providence | Rhode Island | 02914 | — |
| Vanguard Study Site | Jackson | Tennessee | 38305 | — |
| Vanguard Study Site | Milan | Tennessee | 38328 | — |
| Vanguard Study Site | Austin | Texas | 78735 | — |
| Vanguard Study Site | Carrollton | Texas | 75010 | — |
| Vanguard Study Site | Houston | Texas | 77058 | — |
| Vanguard Study Site | McAllen | Texas | 78504 | — |
| Vanguard Study Site | Plano | Texas | 75024 | — |
| Vanguard Study Site | Bountiful | Utah | 84010 | — |
| Vanguard Study Site | St. George | Utah | 84790 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03605862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2022 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03605862 live on ClinicalTrials.gov.